Elsö hazai tapasztalatok pozitron emissziós tomográfiás (PET) vizsgálatokkal. PET munkacsoport tagjai.

Translated title of the contribution: First Hungarian experiences with positron emission tomography (PET) studies. Members of the PET working group

L. Trón, O. Ésik, K. Borbély, B. Clemens, L. Csernay, T. Csépány, L. Csiba, I. Degrell, P. Halász, A. Holló, A. Illés, J. Kollár, Z. Kószegi, G. Németh, L. Novák, I. Nyáry, L. Pávics, J. Sikula, S. Szakáll, B. Gulyás

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Diagnostic investigations commenced on the 28th of June 1994 in Hungary's and Central Europe's first PET Centre at the University Medical School of Debrecen. The Centre is equipped with a GE 4096 Plus whole body PET scanner. A metabolic tracer, 18F-deoxy-D-glucose (FDG), was used in the investigations. During the first 15 months 249 PET investigations were made in the Centre of which 242 were diagnostic and 7 normal subjects served as control for the patient studies with brain scans. The number of oncological indications (intra- and extracranial tumours, Hodgkin's lymphomas) was n = 105 (43.4% of the 242 diagnostic examinations), neurological investigations (without intracranial tumours) formed the dominant group (n = 117; 48.3%), whereas the number of cardiological indications was 20 (8.3%). The oncological studies included those of intracranial tumours (n = 76; 31.4%); thyroid tumours (n = 9; 3.7%); Hodgkin's lymphomas (n = 7; 2.9%) and other extracranial tumours (n = 13; 5.4%). The distribution of different neurological and psychiatric investigations was as follows: localization of focal epileptogen zone (n = 60; 24.8%); differential diagnosis of dementias (n = 30; 12.4%); exploration of cerebrovascular diseases (n = 10; 4.1%); and other neurological diseases (n = 17; 7.0%). The main objective of the cardiological PET investigations was the exploration of viable myocardium. The present paper overviews both the procedures (including administrative issues, as well) and the results of the first 249 FDG-PET investigations.

Original languageHungarian
Pages (from-to)259-269
Number of pages11
JournalOrvosi Hetilap
Volume138
Issue number5
Publication statusPublished - Feb 2 1997

Fingerprint

Positron-Emission Tomography
Neoplasms
Hodgkin Disease
Cerebrovascular Disorders
Hungary
Neurologic Examination
Medical Schools
Psychiatry
Dementia
Myocardium
Thyroid Gland
Differential Diagnosis
Glucose
Brain

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Elsö hazai tapasztalatok pozitron emissziós tomográfiás (PET) vizsgálatokkal. PET munkacsoport tagjai. / Trón, L.; Ésik, O.; Borbély, K.; Clemens, B.; Csernay, L.; Csépány, T.; Csiba, L.; Degrell, I.; Halász, P.; Holló, A.; Illés, A.; Kollár, J.; Kószegi, Z.; Németh, G.; Novák, L.; Nyáry, I.; Pávics, L.; Sikula, J.; Szakáll, S.; Gulyás, B.

In: Orvosi Hetilap, Vol. 138, No. 5, 02.02.1997, p. 259-269.

Research output: Contribution to journalArticle

@article{16483aaab5f041cbab88a52444c87a24,
title = "Els{\"o} hazai tapasztalatok pozitron emisszi{\'o}s tomogr{\'a}fi{\'a}s (PET) vizsg{\'a}latokkal. PET munkacsoport tagjai.",
abstract = "Diagnostic investigations commenced on the 28th of June 1994 in Hungary's and Central Europe's first PET Centre at the University Medical School of Debrecen. The Centre is equipped with a GE 4096 Plus whole body PET scanner. A metabolic tracer, 18F-deoxy-D-glucose (FDG), was used in the investigations. During the first 15 months 249 PET investigations were made in the Centre of which 242 were diagnostic and 7 normal subjects served as control for the patient studies with brain scans. The number of oncological indications (intra- and extracranial tumours, Hodgkin's lymphomas) was n = 105 (43.4{\%} of the 242 diagnostic examinations), neurological investigations (without intracranial tumours) formed the dominant group (n = 117; 48.3{\%}), whereas the number of cardiological indications was 20 (8.3{\%}). The oncological studies included those of intracranial tumours (n = 76; 31.4{\%}); thyroid tumours (n = 9; 3.7{\%}); Hodgkin's lymphomas (n = 7; 2.9{\%}) and other extracranial tumours (n = 13; 5.4{\%}). The distribution of different neurological and psychiatric investigations was as follows: localization of focal epileptogen zone (n = 60; 24.8{\%}); differential diagnosis of dementias (n = 30; 12.4{\%}); exploration of cerebrovascular diseases (n = 10; 4.1{\%}); and other neurological diseases (n = 17; 7.0{\%}). The main objective of the cardiological PET investigations was the exploration of viable myocardium. The present paper overviews both the procedures (including administrative issues, as well) and the results of the first 249 FDG-PET investigations.",
author = "L. Tr{\'o}n and O. {\'E}sik and K. Borb{\'e}ly and B. Clemens and L. Csernay and T. Cs{\'e}p{\'a}ny and L. Csiba and I. Degrell and P. Hal{\'a}sz and A. Holl{\'o} and A. Ill{\'e}s and J. Koll{\'a}r and Z. K{\'o}szegi and G. N{\'e}meth and L. Nov{\'a}k and I. Ny{\'a}ry and L. P{\'a}vics and J. Sikula and S. Szak{\'a}ll and B. Guly{\'a}s",
year = "1997",
month = "2",
day = "2",
language = "Hungarian",
volume = "138",
pages = "259--269",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "5",

}

TY - JOUR

T1 - Elsö hazai tapasztalatok pozitron emissziós tomográfiás (PET) vizsgálatokkal. PET munkacsoport tagjai.

AU - Trón, L.

AU - Ésik, O.

AU - Borbély, K.

AU - Clemens, B.

AU - Csernay, L.

AU - Csépány, T.

AU - Csiba, L.

AU - Degrell, I.

AU - Halász, P.

AU - Holló, A.

AU - Illés, A.

AU - Kollár, J.

AU - Kószegi, Z.

AU - Németh, G.

AU - Novák, L.

AU - Nyáry, I.

AU - Pávics, L.

AU - Sikula, J.

AU - Szakáll, S.

AU - Gulyás, B.

PY - 1997/2/2

Y1 - 1997/2/2

N2 - Diagnostic investigations commenced on the 28th of June 1994 in Hungary's and Central Europe's first PET Centre at the University Medical School of Debrecen. The Centre is equipped with a GE 4096 Plus whole body PET scanner. A metabolic tracer, 18F-deoxy-D-glucose (FDG), was used in the investigations. During the first 15 months 249 PET investigations were made in the Centre of which 242 were diagnostic and 7 normal subjects served as control for the patient studies with brain scans. The number of oncological indications (intra- and extracranial tumours, Hodgkin's lymphomas) was n = 105 (43.4% of the 242 diagnostic examinations), neurological investigations (without intracranial tumours) formed the dominant group (n = 117; 48.3%), whereas the number of cardiological indications was 20 (8.3%). The oncological studies included those of intracranial tumours (n = 76; 31.4%); thyroid tumours (n = 9; 3.7%); Hodgkin's lymphomas (n = 7; 2.9%) and other extracranial tumours (n = 13; 5.4%). The distribution of different neurological and psychiatric investigations was as follows: localization of focal epileptogen zone (n = 60; 24.8%); differential diagnosis of dementias (n = 30; 12.4%); exploration of cerebrovascular diseases (n = 10; 4.1%); and other neurological diseases (n = 17; 7.0%). The main objective of the cardiological PET investigations was the exploration of viable myocardium. The present paper overviews both the procedures (including administrative issues, as well) and the results of the first 249 FDG-PET investigations.

AB - Diagnostic investigations commenced on the 28th of June 1994 in Hungary's and Central Europe's first PET Centre at the University Medical School of Debrecen. The Centre is equipped with a GE 4096 Plus whole body PET scanner. A metabolic tracer, 18F-deoxy-D-glucose (FDG), was used in the investigations. During the first 15 months 249 PET investigations were made in the Centre of which 242 were diagnostic and 7 normal subjects served as control for the patient studies with brain scans. The number of oncological indications (intra- and extracranial tumours, Hodgkin's lymphomas) was n = 105 (43.4% of the 242 diagnostic examinations), neurological investigations (without intracranial tumours) formed the dominant group (n = 117; 48.3%), whereas the number of cardiological indications was 20 (8.3%). The oncological studies included those of intracranial tumours (n = 76; 31.4%); thyroid tumours (n = 9; 3.7%); Hodgkin's lymphomas (n = 7; 2.9%) and other extracranial tumours (n = 13; 5.4%). The distribution of different neurological and psychiatric investigations was as follows: localization of focal epileptogen zone (n = 60; 24.8%); differential diagnosis of dementias (n = 30; 12.4%); exploration of cerebrovascular diseases (n = 10; 4.1%); and other neurological diseases (n = 17; 7.0%). The main objective of the cardiological PET investigations was the exploration of viable myocardium. The present paper overviews both the procedures (including administrative issues, as well) and the results of the first 249 FDG-PET investigations.

UR - http://www.scopus.com/inward/record.url?scp=0031546442&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031546442&partnerID=8YFLogxK

M3 - Article

C2 - 9064629

AN - SCOPUS:0031546442

VL - 138

SP - 259

EP - 269

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 5

ER -